Verdict
Talkiatry is the leading insurance-first online psychiatry platform in the US — and for users seeking medication management with a board-certified MD via insurance, it's the strongest pick in the category. Founded in 2020, Talkiatry employs (rather than contracts with) its psychiatrists, which produces tighter clinical quality control than 1099-contractor models like Cerebral. The platform is in-network with most major US health insurers and operates in 43+ states.
Talkiatry is not a fit for users who don't have insurance — it's not designed as a low-friction direct-pay platform. For uninsured users, Cerebral, Hims, or Brightside are typically more accessible (with the regulatory caveats around each).
Pricing
- In-network insurance: typical copay $0–$50 per visit, depending on plan. The full visit cost is billed to insurance.
- Direct-pay (uninsured or out-of-network): initial 60-minute psychiatric evaluation around $300; follow-ups around $150. Direct-pay is available but is not the typical Talkiatry pathway.
- Therapy: Talkiatry historically focused on psychiatric medication management; talk therapy is offered through some plans but is not the platform\'s primary service.
Pricing changes; verify on talkiatry.com — check insurance eligibility before booking.
Strengths
- Insurance-first model. In-network with Aetna, Anthem, BCBS, Cigna, UnitedHealthcare, Optum, Humana, and several Medicare Advantage plans. The platform does not accept Medicaid in most states.
- Employed psychiatrists, not contractors. Talkiatry W-2 employs its psychiatrists, which is unusual in DTC psychiatry. This produces tighter clinical quality control than 1099-contractor models and is one of the platform\'s real differentiators versus Cerebral and Hims.
- Board-certified MDs only. All Talkiatry clinicians are board-certified psychiatrists (MD/DO), not nurse practitioners or counsellors. For users specifically wanting MD-level prescribing, this is the strongest signal in the DTC psychiatry category.
- Specialty depth. Talkiatry has structured specialty programs for ADHD, anxiety, depression, PTSD, OCD, women\'s mental health, and substance-use disorders.
- No FTC enforcement actions. As of May 2026, Talkiatry has not faced FTC enforcement of the kind BetterHelp (2023) and Cerebral (2024) settled. Privacy posture appears stronger.
Weaknesses
- Not in all 50 states. Talkiatry operates in 43+ states as of 2026; coverage continues expanding but check eligibility before sign-up.
- Long wait times for first appointment. Demand exceeds supply — first available appointment is often 2–4 weeks out, longer in some states. Once established, follow-ups schedule faster.
- Not Medicaid-friendly. Most Talkiatry plans do not accept Medicaid, narrowing access for low-income patients.
- Controlled-substance prescribing varies. Talkiatry can prescribe controlled substances (including Schedule II ADHD stimulants in some states under appropriate clinical evaluation), but the post-2022 telehealth industry-wide caution applies. Some clinicians may decline ADHD stimulant prescribing or require an in-person evaluation first.
- Not a fit for crisis or acute psychiatric emergencies. Talkiatry is appropriate for stable medication management and ongoing psychiatric care. Active suicidal ideation or acute decompensation requires emergency services (988 / ER), not telehealth scheduling.
Talkiatry vs Cerebral
Both offer online psychiatry; the differences matter:
- Clinician model: Talkiatry employs board-certified MDs only. Cerebral uses a mix of nurse practitioners, physician assistants, and MDs as 1099 contractors.
- Insurance: Talkiatry is insurance-first. Cerebral has limited insurance coverage and is primarily direct-pay.
- Regulatory track record: Talkiatry has no FTC enforcement actions. Cerebral settled with the FTC in 2024 ($7M) over privacy violations and faced 2022 DEA scrutiny over controlled-substance prescribing.
- Pricing: Talkiatry copays often $0–$50 in-network. Cerebral subscription pricing typically $85–$365/month direct-pay.
For insured users, Talkiatry is the stronger pick on every dimension. For uninsured users, Cerebral may be more accessible but carries the regulatory caveats described in our Cerebral review.
Bottom line
Talkiatry is the right pick for insured users seeking medication management with a board-certified MD. The W-2 employment model, MD-only clinician roster, insurance-first pricing, and clean regulatory track record make it the strongest DTC psychiatry option in the category for users whose insurance covers it. For talk therapy alone (no medications), BetterHelp or Talkspace are typically a better fit. For uninsured psychiatry access, Cerebral or Hims are more accessible but carry trade-offs.